Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ACH · Entity 6858 | Director | May 14, 2026 | May 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date May 14, 2026 · Filed May 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,242 |
Reported balance
After 2026-05-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 31,191 · Balance 90,242 F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 18, 2026 13:13 UTC | ACCENDRA HEALTH INC/VA/ ACH · Entity 6858 | GrantCommon Stock | 31,191 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-26-000027 · form4.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,242 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| May 15, 2025 Filed May 16, 2025 22:08 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 28,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-009725 · form4.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,051 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| May 09, 2024 Filed May 10, 2024 20:06 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 11,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-009884 · form4.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,137 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| May 12, 2023 Filed May 12, 2023 23:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 9,344 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-010975 · form4.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,983 F1 · security: Restricted stock grant which vests the earlier of (i) one year from the grant date and (ii) the date of the next annual meeting that is at least 50 weeks following the grant date. Read SEC document |
| April 29, 2022 Filed May 3, 2022 12:32 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-011324 · form4.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,639 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| April 29, 2021 Filed May 3, 2021 20:47 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,098 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000084 · edgar.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,708 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 01:29 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 610 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000043 · edgar.xml · nonDerivative · entry 1 Klemash Stephen W · CIK 0001848495 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610 F1 · security: Restricted stock with one year vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.